` ESPR (Esperion Therapeutics Inc) vs NOVO B (Novo Nordisk A/S) Comparison - Alpha Spread

ESPR
vs
NOVO B

Over the past 12 months, ESPR has outperformed NOVO B, delivering a return of -56% compared to the NOVO B's 57% drop.

Valuation Comparison

ESPR Intrinsic Value
4.77 USD
Undervaluation 79%
Intrinsic Value
Price
NOVO B Intrinsic Value
627.67 DKK
Undervaluation 31%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Esperion Therapeutics Inc
NASDAQ:ESPR
1.01 USD
Novo Nordisk A/S
CSE:NOVO B
435.25 DKK

Financials Comparison

Growth Over Time
ESPR vs NOVO B

ESPR
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Esperion Therapeutics Inc
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
ESPR vs NOVO B

ESPR
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Esperion Therapeutics Inc
NASDAQ:ESPR
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

ESPR
65.3%
NOVO B
84.3%

Operating Margin

ESPR
-36.6%
NOVO B
44.6%

Net Margin

ESPR
-59%
NOVO B
34.5%

FCF Margin

ESPR
-38.7%
NOVO B
24.5%

ROE

ESPR
42.5%
NOVO B
88.1%

ROA

ESPR
-44%
NOVO B
26.6%

ROIC

ESPR
-74.3%
NOVO B
30.4%

ROCE

ESPR
-72.5%
NOVO B
70%

Stocks Performance

Stocks Performance
ESPR vs NOVO B

Loading
ESPR
NOVO B
Add Stock
www.alphaspread.com

Performance Gap
ESPR vs NOVO B

Loading
ESPR
NOVO B
Difference
www.alphaspread.com

Performance By Year
ESPR vs NOVO B

Loading
ESPR
NOVO B
Add Stock
Unlock Full Access to Alpha Spread
Create Free Account